EUVIMEDSkopri EUVIMED
Open access

Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study

Z Einbeigi, D Bergström, T Hatschek, M Malmberg

Clinical medicine. Oncology · 2008

DOI: 10.4137/cmo.s1027 ↗

At a glance

Journal article in Clinical medicine. Oncology, 2008. Written by Z Einbeigi and 3 co-authors. Institution: Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden. 24 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Thirteen patients with untreated metastatic breast cancer received epirubicin 60 mg/m 2 , paclitaxel 155 mg/m 2 (both day 1) and capecitabine 665 mg/m 2 twice daily (days 1-14) every 21 days, with intra-patient dose escalation/reduction. Grade 3/4 events were infrequent. Nine patients (69%) achieved an objective response. Median time to progression and overall survival were 6.6 and 23.5 months, respectively.

Subjects

Author keywords

capecitabineepirubicinfirst-line chemotherapymetastatic breast cancerpaclitaxelphase I/II

Authors and institutions

  • Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden.

Cite

APA

Einbeigi, Z., Bergström, D., Hatschek, T., & Malmberg, M. (2008). Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study. Clinical medicine. Oncology. https://doi.org/10.4137/cmo.s1027

Vancouver

Einbeigi Z, Bergström D, Hatschek T, Malmberg M. Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study. Clinical medicine. Oncology. 2008. doi:10.4137/cmo.s1027

BibTeX
@article{Einbeigi2008,
  author = {Einbeigi, Z and Bergström, D and Hatschek, T and Malmberg, M},
  title = {Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: A Pilot Phase I/II Feasibility Study},
  journal = {Clinical medicine. Oncology},
  year = {2008},
  doi = {10.4137/cmo.s1027}
}
Start for free →